Introduction
Vitamins and micronutrients are essential organic substances in the metabolic processes of living things, which aid the assimilation of nutrients within the human body. Because vitamins participate in multiple functions (antioxidants, immune function, endothelial homeostasis, bone metabolism, connective tissue stability, central nervous system modulation, etc), of the organism and constitute one of the main pillars for its growth, certain vitamin deficits have been associated with neurological, hematological, musculoskeletal, endocrinological, immunological and cardiovascular defects, for these reason, vitamin deficits require an effective and comprehensive approach because they are complex entities from clinical, ethical and humanistic perspectives, and supplementations is only recommended in conditions of nutritional supplementation deficits1-4.
Although the consumption of vitamin supplements increased over the past decades due to their possible health benefits5, approximately two billion people have low levels of the main vitamins and minerals6, of which an estimated 30-50% have a vitamin D deficit7, and approximately 8.5 to 51% are deficient in vitamin B121. Certain circumstances or special procedures are known to be associated with decreased vitamin levels in the body; for example, deficits of vitamins A, B1, B6, B9, B12, D and E have been documented in patients after bariatric surgery8,9.
Consequently, vitamin supplement consumption has increased, with an estimated 49 to 52% of United States citizen adults using vitamin supplements regularly5, figures that may reach up to 63% among people aged more than 60 years10 and up to 70% among those older than 70 years11. Vitamin consumption is more frequent among women, patients with low body mass index, non-smokers and those with high levels of education, socioeconomic status and physical activity12. Most vitamin supplementation is accompanied by mineral supplementation, including calcium; however, according to some studies, most people consume only 30% of the daily recommended calcium intake, a mineral for which deficiencies are associated with osteopenia and osteoporosis13.
Scarce information exists regarding the frequency of vitamin supplement use in Colombia; thus, understanding their use might establish a baseline upon which strategies could be proposed to harmonizetheiruse, e.g., increasingtheir dispensation where needs are identified or decreasing their dispensation based on inappropriate use. Based on this hypothesis, we sought to determine prescription patterns of vitamins in a group of patients affiliated to the Health System of Colombia (SGSSS) in the year 2016.
Materials and methods
A cross-sectional study on vitamin prescription patterns was conducted in a population of approximately 3.5 million people affiliated with the SGSSS-participating program of two insurers, called Health Promoting Companies (EPS for its initials in Spanish). The characteristics of patients treated with vitamins were analyzed in the period between July 1 and September 30, 2016 in all Colombian cities where they were prescribed.
Data was taken from all individuals of any ages and sex who used this group of medications, attended an outpatient clinic visit and whose treatment was maintained uninterruptedly for at least three months were included (sample calculation was not performed). This requirement was intended to ensure that patients were on an approximately stable treatment, reflecting medication tolerance and adherence. Exclusion criteria were not considered.
Based on the information concerning the consumption of medications of the affiliated population, obtained systematically by the dispensing company Audifarma SA. Each dispensing of the medication is registered together with sociodemographic and diagnostic data, a database was designed to collect the following groups of patient variables: sociodemographic variables were evaluated (sex, age and city), Pharmacological variables (Prescribed active ingredient, vitamin or micronutrient supplement) and its formulation, dosage and dosage interval. The daily defined dose (DDD) and the DDD per thousand inhabitants per day were used as the measures of use. Comedications were also evaluated and were accepted as a proxy indicator of chronic disease, considering the following associations: a) antidiabetics and insulins/ diabetes mellitus; B) analgesics (nonsteroidal anti-inflammatory drugs, acetaminophen, corticosteroids)/chronic pain; C) antirheumatics/ rheumatoid arthritis; D) antidepressants/depressive disorder; E) lipid-lowering agents/dyslipidemia; F) thyroid hormone preparations/hypothyroidism; G) nitrovasodilators/ischemic heart disease; and H) antihypertensives and diuretics/arterial hypertension.
The protocol was endorsed by the Bioethics Committee of the Technological University of Pereira under the category of “research without risk”, and the principles established by the Declaration of Helsinki were respected.
Statistical analysis
The statistical package SPSS Statistics, version 23.0 (IBM, USA) for Windows was used for the data analysis. Descriptive statistics were used, including measures of central tendency, position and dispersion depending on the normal behavior of the continuous variables (Shapiro-Wilk or Kolmogorov- Smirnov test) and frequencies and proportions for categorical variables. Student t-tests or ANOVA were used to compare quantitative variables and X2 was used for categorical variables. Logistic regression models were used, as dependent variables with use of vitamins as monotherapy or in combined therapy and use or no use of comedication, whereas covariables were those factors demonstrating significant associations in the bivariate analyses. A p-value <0.05 was determined as the level of statistical significance.
Results
A total of 9998 patients affiliated with these EPS were prescribed some type of vitamin supplement. A female predominance was observed, totaling 8341 women (83.4%). Regarding the age distribution, 2.2% were younger than 18 years, 19.2% were aged between 18 and 34 years, 33.8% were aged between 35 and 64 years and 34.9% were older than 65 years. No age data was available regarding the remaining 9.9%. Figure 1 shows the population distribution by age and sex. The mean age was 57.7 ± 18.7 years (range 0-100 years) with a significant difference between men and women (59.4 ± 20.2 years versus 57.4 ± 18.4 years respectively; p < 0.001) (Figure 1).
The most commonly formulated vitamins and supplements were vitamin D (58.0%), calcium (55.0%), folic acid (25.0%), iron (13.0%) and thiamine (8.0%). Table 1 summarizes the prescription patterns of the major vitamins dispensed to outpatients, including their frequency, average dose and DDD. Table 2 summarizes the distribution of vitamins for the age groups and the most frequently prescribed types in the sample evaluated (Table 1 and 2).
Medication | Prescription | Prescribed dose | nDDD | DDD X 1000 | H: M relation | Mean age (SD) | |||
# Patients | % | Mean | Standard deviation | Mode | inhabitants / day | ||||
Vitamin D (IU / day) | 5847 | 58.5 | 388.5 | 657.3 | 200 | 0.49 | 0.95 | 1:10 | 62.6 |
Calcium (mg / day) | 5505 | 55.1 | 706.7 | 438.7 | 600 | 1:8 | 62.8 | ||
Folic Acid (mg / day) | 2523 | 25.2 | 1.2 | 0.9 | 1 | 2.90 | 2.45 | 1:5 | 19.8 |
Iron (mg / day) | 1330 | 13.3 | 290.8 | 77.7 | 300 | 1.45 | 0.65 | 1:9 | 40.9 |
Thiamine (mg / day) | 828 | 8.3 | 317.5 | 92.9 | 300 | 6.35 | 0.11 | 1:2 | 66.2 |
Ascorbic acid (mg / day) | 667 | 6.7 | 645.9 | 352.3 | 500 | 3.23 | 0.72 | 1:2 | 56.0 |
Cyanocobalamin (mg / day) | 423 | 4.2 | 0.1 | 0.1 | 0,033 | 0.07 | 0.01 | 1:2 | 61.4 |
Vitamin A (IU / day) | 152 | 1.5 | 59367.2 | 22643.7 | 50000 | 1.19 | 0.06 | 1:1 | 40.6 |
Vitamin E (mg / day) | 34 | 0.3 | 645.1 | 265.1 | 800 | 3.23 | 0.04 | 1:0.7 | 40.5 |
Vitamin K (mg / day ) | 3 | 0.03 | 1.8 | 1.9 | 0.09 | 0.00 | 6.6 |
Source: authors.
<18 years | 18 to 44 years | 45 to 65 years | > 65 years | |||||
Medication | N = 218 (2.2%) | Mean dose | N = 1932 (19.3%) | Mean dose | N = 3398 (3. 4%) | Mean dose | N = 3469 (34.7%) | Mean dose |
Vitamin D | 49 (22%) | 964.2 | 531 (27%) | 451.2 | 2290 (67%) | 412.3 | 2332 (67%) | 356.3 |
Calcium | 37 (17%) | 735.0 | 495 (26%) | 879.7 | 2144 (63%) | 719.1 | 2206 (15%) | 661.9 |
Folic acid | 52 (24%) | 1.0 | 1073 (56%) | 1.1 | 720 (21%) | 1.1 | 512 (15%) | 1.3 |
Iron | 41 (19%) | 267.9 | 822 (63%) | 294.5 | 149 (4%) | 275.0 | 230 (7%) | 288.8 |
Thiamine | 2 (1%) | 550.0 | 63 (3%) | 295.2 | 279 (8%) | 324.5 | 430 (12%) | 318.4 |
Ascorbic acid | 64 (29%) | 370.5 | 93 (5%) | 647.2 | 211 (6%) | 660.2 | 240 (7%) | 690.2 |
Cyanocobalamin | 1 (0%) | 0.2 | 57 (3%) | 0.1 | 179 (5%) | 0.1 | 146 (4%) | 0.1 |
Source: authors.
Monotherapy and polytherapy
From all the patients included in the study, 3919 (39.2%) were prescribed only one vitamin or nutritional supplement, and the remainder were prescribed two or more active nutrients. The most frequent combinations were calcium and vitamin D (n = 5505, 55.1%); iron and folic acid (n = 848, 8.4%); vitamin D and folic acid (n = 554, 5.5%); calcium and folic acid (n = 552, 5.5%); and thiamine and vitamin D (n = 185, 1.8%).
Comedications
Of the total number of patients, 7727 (77.3%) received concomitant treatment with one or more of the following groups of drugs: antihypertensives, analgesics and antipyretics, statins, nitrates, thyroid hormones and corticosteroids. Their frequencies and other medications were evaluated (Table 3).
Binary logistic regression analysis of comedication revealed that the following variables were significantly associated with a lower probability of receiving any other drug: age between 14 and 18 years (OR: 0.23, 95% CI: 0.15-0.33), age between 18 and 45 years (OR: 0.37, 95% CI: 0.30-0.46), iron supplementation (OR: 0.59, 95% CI: 0.50-0.69) and being female (OR: 0.75; 95% CI: 0.64-0.86). Age greater than 65 years (OR: 1.24; 95% CI: 1.02-1.51), formulations with folic acid (OR: 3.10; 95% CI: 2.69-3.59); thiamine (OR: 2.75; 95% CI: 2.15-3.50), calcium + vitamin D (OR: 1.61, 95% CI: 1.42-1.82) or treatment in one of the cities of Manizales (OR: 1.76, 95% CI: 1.38-2.25), Bucaramanga (OR: 1.71, 95% CI: 1.28-2.27), Bogota (OR: 1.71; 95% CI: 50-1.95), Barranquilla (OR: 1.52, 95% CI: 1.22-1.90) or Cartagena (OR: 1.47, 95% CI: 1.16-1.85) were associated with a greater probability of receiving some type of comedication.
Variables | Bogotá | Barranquilla | Manizales | Cartagena | Bucaramanga | Colombia |
n=6140 | n=645 | n=559 | n=523 | n=466 | n=9998 | |
Mean age | 58.1 | 56.5 | 58.3 | 47.6 | 64.8 | 57.7 |
Women (%) | 85.4 | 72.2 | 83.7 | 80.1 | 78.1 | 83.4 |
Monotherapy (%) | 86.5 | 65.7 | 75.1 | 60.6 | 81.3 | 80.3 |
Comedication (%) | 87.8 | 77.5 | 80.5 | 71.3 | 82.6 | 77.3 |
Prescription (%) | ||||||
Vitamin D | 67.6 | 30.7 | 68.5 | 17.4 | 38.4 | 58.5 |
Calcium | 65.7 | 30.2 | 66.0 | 17.2 | 37.3 | 55.1 |
Folic acid | 20.7 | 37.8 | 28.4 | 52.6 | 11.4 | 25.2 |
Iron | 6.7 | 24.0 | 15.0 | 47.2 | 9.2 | 13.3 |
Thiamine | 5.1 | 18.6 | 5.2 | 4.4 | 45.5 | 8.3 |
Ascorbic acid | 5.5 | 16.3 | 1.3 | 14.7 | 9.4 | 6.7 |
Cyanocobalamin | 3.2 | 14.7 | 6.1 | 5.4 | 2.3 | 4.2 |
Vitamin A | 1.8 | 1.4 | 0.5 | 0.0 | 0.9 | 1.5 |
Vitamin E | 0.4 | 0.2 | 0.0 | 0.2 | 0.2 | 0.3 |
Vitamin K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Comedication (%) | ||||||
Antihypertensives | 42.9 | 42.0 | 44.9 | 41.10 | 56.4 | 41.7 |
Analgesics | 31.7 | 38.4 | 29.2 | 29.6 | 32.2 | 31.6 |
Statins | 27.3 | 24.7 | 39.0 | 25.6 | 39.7 | 27.5 |
Anti-ischemic | 24.7 | 21.9 | 24.3 | 22.6 | 31.5 | 24.3 |
Thyroid Hormones | 24.7 | 21.9 | 24.3 | 8.8 | 22.3 | 23.4 |
DMARDs | 15.1 | 11.8 | 20.8 | 6.1 | 12.0 | 13.5 |
Antidepressants | 11.7 | 14.1 | 22.4 | 7.5 | 17.8 | 12.9 |
Corticosteroids | 12.9 | 17.4 | 21.6 | 6.9 | 10.3 | 12.8 |
Antidiabetics | 10.5 | 10.1 | 9.5 | 12.4 | 17.8 | 10.6 |
NSAIDs | 9.1 | 14.7 | 6.3 | 4.8 | 17.8 | 9.5 |
Source: authors.
Comparison by city
We identified 18 cities in the country in which patients were prescribed some types of vitamins and supplements. Table 3 shows a comparison of some usage indicators for the five cities with the highest number of patients, which represent 83.3% of the usage by all the evaluated populations, and the usage indicators of the country as a whole (Table 3).
Discussion
This study describes the prescription patterns of vitamins and other supplements among patients affiliated in two different EPS of the Colombian Health System. Vitamin and micronutrient usage habits in the population with supplement prescription, such as those for vitamin D, calcium, folic acid and iron, among others, were identified. These real- life utilization results may allow optimized and methodological prescribing and improve the quality of care, cost and safety of patient therapy.
A predominance of vitamin and supplement use among women was observed (5:1 ratio). Some studies of over-the-counter use in Europe and Asia describe a similar trend; for example, in Europe in the study by Skeie et al in 2009, they found up to 10 times more supplements use in women, especially between the ages of 35 and 74, and in the United States in the study carried out by Kantor et al in 2016 the relationship is slightly higher in women, although the way of evaluating the use of supplements was different. However, in our study vitamins and supplements are drugs prescribed through a health system14-17.
Adults older than 65 years received more vitamin prescriptions. According to a study conducted in the US in 2016, 72% of older adults had consumed vitamins in the prior month, showing that consumption increases with advanced age16,17. Unlike the study by Piccano et al. in the US, which showed that children aged 4 to 8 years were the main consumers of vitamins, we found in this study that vitamins were prescribed to only 2.2% of those younger than 18 years18.
On average, the doses that patients were receiving were higher than those recommended by the WHO for each vitamin or supplement except for calcium and vitamin D19, which were generally less than 60% of the doses established for each of these nutrients.
The prescription of a joint formulation of calcium and vitamin D was more frequent than that of both compounds separately, mainly in the population older than 45 years, which is likely related to the indication for improving bone mineral density in patients at risk of osteoporosis, notably because such combination has shown better results, with a 12% greater reduction in fracture risk compared to the administration of calcium alone4,20.
The use of folic acid was concentrated in the group of women aged between 18 and 45 years; thus, it is hypothesized that its use in a population of childbearing age might have been indicated for the prevention of fetal neural tube alterations21, pattern of use similar to that reported for example by Wong et al in the United States in 2019, where women of reproductive age consume more folic acid supplement, especially between 18-24 years and mainly during pregnancy and the preconception period22. However, a study conducted in 2013 in major cities (15 different institutions) in Colombia found inadequate folic acid usage in a population of pregnant patients due to insufficient consumption21. Folic acid supplementation is a safe strategy recommended by international organizations for this indication23,24 and for the management of anemias due to the deficiency of this micronutrient in other population groups such as those older than 45 years, in whom its use was also frequent25,26.
Similar to folic acid, a significant number of patients mainly in the fertile age group (18-45 years) were identified as receiving ferrous sulfate. A study indicated that in 2011, approximately 528 million women of reproductive age had anemia, with iron deficiency the cause in 50% of the cases27; therefore, its use in this group should prevent this type of anemia during gestation23.
Vitamin C was prescribed more commonly in children aged less than 18 years. Although it has been used for years for the prevention of the common cold, no evidence supports that expected effect in the general population28,29. Thus, inquiring about the indications of its use is pertinent based on its poor therapeutic benefit4.
Most medications were prescribed in patients with pathologies of cardiovascular origin, for which drug-vitamin interactions are not clinically relevant; however, such interactions require consideration regarding the group of patients being treated as does the sum of medications that may lead to inappropriate polypharmacy and reduced adherence to treatment30.
On a global level, the consumption of multivitamins has grown more than that of individual vitamin or mineral formulations, which was also evident in this study, notwithstanding the fact that over-the- counter products were not studied16,31. Typically, multivitamin use is associated with the intention of improving or maintaining health conditions without prior consultation with a health professional; however, the fact that these are not harmless products warrants consideration31.
The differences found in the patterns of use of vitamins in the Colombian cities included in the study as related to the frequency of use were expected because discrepancies in care, medical education and particularly prescription habits are persistent findings in drug-epidemiological studies. These variations, which are important because of their medical, social and economic implications, are related to patient characteristics (age, sex and comorbidity) and to professional practice styles that originate from personal factors and the academic training of physicians32,33.
This study has limitations regarding the interpretation of some results, such as the inclusion of patients from only two EPSs, which excludes the possibilities of extrapolation to subsidized populations and assessments such as the use of vitamin supplements without medical prescription or use in over-the-counter supplement, along with the possible indications or diagnoses associated with such use. However, important study strengths exist such as the broad sample used, the reliability of the data regarding the included dispensations and, considering that vitamin and supplement use in Colombia has not been described previously, its innovation.
Conclusions
The aforementioned results indicate that the vitamins and supplements most widely used in daily medical practice are vitamin D and calcium, generally combined, followed by folic acid, iron and thiamine in women older than 35 years, and in general in higher doses than recommended; moreover, vitamin and supplement users are frequently receiving medications for various comorbidities, particularly arterial hypertension, arthropathies and dyslipidemia. The findings of this pharmacoepidemiological study provide decision makers and prescribing physicians with a useful tool because they offer them an understanding of and evidence for their real-world uses.